As is recommended for all patients, Michael DeBakey had an advance directive: he had stated, while in good health, what approach to medical care he would want if he became ill and unable to speak for himself. He specifically indicated that he would not want to undergo major surgery.
A cardinal principle of contemporary medical ethics is that patients have the right to make this type of decision and that physicians are obligated to follow their wishes. To disregard a patient's preferences once he loses the ability to make decisions -- as occurred when DeBakey's wife reportedly stormed into a late-night hospital ethics committee meeting and demanded that the surgery take place -- violates the hard-won respect for patients' autonomy gained over the past 20 years.
Much of the commentary about the case has centered on whether a patient's wishes can be overridden, even by loving family members. What has largely been left out of the discussion is whether it is ever appropriate to perform invasive, dangerous, and expensive surgery on 97-year-olds -- even if they want it.
The operation performed on DeBakey involved putting him on cardiac bypass and opening the aorta, the artery that carries blood from the heart to most of the major organs of the body. The damaged part of the aorta was then replaced with a synthetic graft.
The risks were high: in a group of elderly patients who had the procedure, the oldest of whom was 77, 18 percent died while hospitalized. Moreover, surviving the surgery does not mean returning to one's usual state of health in a matter of a few weeks. It typically means, as DeBakey experienced and as his physicians anticipated, an extended hospitalization marked by reliance on machines, multiple complications and considerable suffering.
DeBakey spent three months in the hospital, much of the time unable to speak or eat, let alone leave his bed, read, or interact with others. He was attached to respirator and to another machine to clear wastes from his body and was fed through a stomach tube. The cost of his hospital stay is estimated to have exceeded US$1 million.
While DeBakey is glad to be alive, how many people should we subject to the grueling treatment that he endured for the chance of a few more weeks or months of life? Is it reasonable for 99 or perhaps 999 people to suffer for days or months, only to die from complications of surgery, because one person might live?
The number of potentially life-prolonging technologies offered by contemporary medicine is proliferating. An implantable cardioverter defibrillator can jolt the heart back to normal if an irregular, life-threatening rhythm develops in patients who have had a heart attack. The left ventricular assistance device is a partial artificial heart used in patients dying of heart failure. Sophisticated biopharmaceuticals -- drugs typically used in patients with extremely advanced cancers -- are also multiplying.
Some of these therapies can provide additional months or even years of life to people in their prime. But does their use make sense for the oldest old, especially when they are invasive and costly?
When the baby boomers begin turning 65 in 2010, they will account for 13 percent of the population in the US; by 2050, 21 percent will be over 65 and 5 percent will be over 85. Medicare expenditure -- the money spent by the government insurance program for the elderly -- is projected to soar from 2.6 percent of GDP this year to 9.2 percent in 2050, with technology accounting for over 50 percent of the cost increase.
If we are to have the resources for public goods other than health care -- say, education, national parks and highways, not to mention medical care for children and the poor -- we must put the brakes on technology. In rich countries, this does not mean rationing care based on age alone. But surely the place to start is to limit treatment that is burdensome and expensive, that has a miniscule chance of success, and that is proposed for people at the very end of life. We need to accept human mortality and, as a matter of both practice and policy, concentrate on improving older people's quality of life.
This means assuring compassionate nursing home care, coordinated management of chronic diseases and competent palliative care as death approaches, rather than using ever more technology to try to eke out a little more life. It also means systematically considering cost and life expectancy in decisions about reimbursing high-technology medical care.
Muriel Gillick is an associate professor in the department of ambulatory care and prevention at Harvard Medical School/Harvard Pilgrim Health Care and a geriatric physician at Harvard Vanguard Medical Associates.
Copyright: Project Syndicate
Saudi Arabian largesse is flooding Egypt’s cultural scene, but the reception is mixed. Some welcome new “cooperation” between two regional powerhouses, while others fear a hostile takeover by Riyadh. In Cairo, historically the cultural capital of the Arab world, Egyptian Minister of Culture Nevine al-Kilany recently hosted Saudi Arabian General Entertainment Authority chairman Turki al-Sheikh. The deep-pocketed al-Sheikh has emerged as a Medici-like patron for Egypt’s cultural elite, courted by Cairo’s top talent to produce a slew of forthcoming films. A new three-way agreement between al-Sheikh, Kilany and United Media Services — a multi-media conglomerate linked to state intelligence that owns much of
The US and other countries should take concrete steps to confront the threats from Beijing to avoid war, US Representative Mario Diaz-Balart said in an interview with Voice of America on March 13. The US should use “every diplomatic economic tool at our disposal to treat China as what it is... to avoid war,” Diaz-Balart said. Giving an example of what the US could do, he said that it has to be more aggressive in its military sales to Taiwan. Actions by cross-party US lawmakers in the past few years such as meeting with Taiwanese officials in Washington and Taipei, and
The Republic of China (ROC) on Taiwan has no official diplomatic allies in the EU. With the exception of the Vatican, it has no official allies in Europe at all. This does not prevent the ROC — Taiwan — from having close relations with EU member states and other European countries. The exact nature of the relationship does bear revisiting, if only to clarify what is a very complicated and sensitive idea, the details of which leave considerable room for misunderstanding, misrepresentation and disagreement. Only this week, President Tsai Ing-wen (蔡英文) received members of the European Parliament’s Delegation for Relations
Denmark’s “one China” policy more and more resembles Beijing’s “one China” principle. At least, this is how things appear. In recent interactions with the Danish state, such as applying for residency permits, a Taiwanese’s nationality would be listed as “China.” That designation occurs for a Taiwanese student coming to Denmark or a Danish citizen arriving in Denmark with, for example, their Taiwanese partner. Details of this were published on Sunday in an article in the Danish daily Berlingske written by Alexander Sjoberg and Tobias Reinwald. The pretext for this new practice is that Denmark does not recognize Taiwan as a state under